Explore

Search ClinicalTrials.gov

Find trials by condition, intervention, sponsor, or location. Filter by status, phase, and study type — or enter an NCT ID to jump straight to a trial.

Search trials by disease or condition

Enter a condition, keyword, or NCT ID

RecruitingPhase IIIPhase III recruiting

StatusPhaseStudy typeSort

Results for “multiple sclerosis”

Robotics for Mobility Rehabilitation in MSCompleted
NCT05102682Phase 1Updated Feb 22, 2024
Sponsor: East Kent Hospitals University NHS Foundation Trust
Multiple Sclerosis · MS
United Kingdom
Increasing Physical Activity for Adults With Multiple Sclerosis (MS)Recruiting
NCT06270641NAUpdated Feb 22, 2024
Sponsor: University of Washington
Multiple Sclerosis (MS) · Fatigue · Physical Inactivity
United States
Pilates Training in Multiple SclerosisCompleted
NCT04011579NAUpdated Feb 22, 2024
Sponsor: Fondazione Italiana Sclerosi Multipla
Multiple Sclerosis · Physical Activity
Italy
The Effect of Dual Task On Upper Extremity Functions In Multiple Sclerosis PatientsCompleted
NCT06270342N/AUpdated Feb 21, 2024
Sponsor: Kutahya Health Sciences University
Multiple Sclerosis
Turkey (Türkiye)
RRMS: Disease PROgression and Myeloid Profiling After Bone Marrow TRANSPLANTation and Second Line TherapiesRecruiting
NCT06267781N/AUpdated Feb 20, 2024
Sponsor: IRCCS San Raffaele
Multiple Sclerosis
Italy
The Experience in Neurorehabilitation Setting: a Qualitative StudyUnknown
NCT06264037N/AUpdated Feb 16, 2024
Sponsor: IRCCS San Camillo, Venezia, Italy
Rehabilitation · Neurologic Disorder · Stroke · Parkinson Disease
Italy
Effectiveness of TTNS in MS Patients With Lower Urinary Track SymptomsUnknown
NCT06263556NAUpdated Feb 16, 2024
Sponsor: Bakirkoy Dr. Sadi Konuk Research and Training Hospital
Multiple Sclerosis · Lower Urinary Tract Symptoms
Turkey (Türkiye)
Exercise Effects in Multiple SclerosisUnknown
NCT05496881NAUpdated Feb 15, 2024
Sponsor: University of Regina
Multiple Sclerosis, Primary Progressive · Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis, Secondary Progressive · Multiple Sclerosis, Chronic Progressive
Canada
Head Circumference Growth in Children Who Develop Multiple Sclerosis Later in LifeWithdrawn
NCT01377805N/AUpdated Feb 14, 2024
Sponsor: Genetic Disease Investigators
Multiple Sclerosis
United States
Study Evaluating Safety and Tolerability of Escalating Single and Multiple Doses of PIPE-791 and Food Effect in Healthy VolunteersCompleted
NCT05983939Phase 1Updated Feb 14, 2024
Sponsor: Contineum Therapeutics
Multiple Sclerosis
United States
Acceptance and Commitment Therapy in Tuberous Sclerosis ComplexUnknown
NCT05867576NAUpdated Feb 14, 2024
Sponsor: University Hospitals Bristol and Weston NHS Foundation Trust
Tuberous Sclerosis Complex
United Kingdom
The Impact of Parasitic Infection on Multiple Sclerosis and Nephrotic SyndromeUnknown
NCT06256471N/AUpdated Feb 13, 2024
Sponsor: Assiut University
Parasitic Disease
Long Term Special Drug Use-results Surveillance for Mayzent in SPMS PatientsCompleted
NCT04593927N/AUpdated Feb 12, 2024
Sponsor: Novartis Pharmaceuticals
Secondary Progressive Multiple Sclerosis (SPMS)
Japan
Increasing Diagnosis Rates While Reducing Examination Time: Can MR Fingerprinting Deliver on Its Promise?Completed
NCT06251830N/AUpdated Feb 9, 2024
Sponsor: IRCCS Fondazione Stella Maris
Neurodevelopmental Disorders · Neurodegenerative Diseases · Brain Tumor · Multiple Sclerosis
Italy
Efficacy and Safety of Rapamycin Versus Vigabatrin in the Prevention of Tuberous Sclerosis Complex Symptoms in InfantsUnknown
NCT04987463Phase 2, Phase 3Updated Feb 8, 2024
Sponsor: Katarzyna Kotulska
Tuberous Sclerosis Complex
Poland
In-phase Bilateral Exercises in People With Relapsing Remitting Multiple SclerosisCompleted
NCT05367947NAUpdated Feb 7, 2024
Sponsor: Cyprus University of Technology
Multiple Sclerosis
Cyprus
EMRESERVA to Enhance Cognitive Reserve in Multiple SclerosisCompleted
NCT05546424N/AUpdated Feb 7, 2024
Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla
Cognitive Change
Spain
MS-ResearchBiomarkerSRecruiting
NCT05204459N/AUpdated Feb 6, 2024
Sponsor: Cedars-Sinai Medical Center
Multiple Sclerosis · Multiple Sclerosis, Relapsing-Remitting · Multiple Sclerosis, Primary Progressive · Multiple Sclerosis, Secondary Progressive
United States
Reliability and Validity Studies of Turkish Version of Manual Ability Measure-36Completed
NCT06122740N/AUpdated Feb 6, 2024
Sponsor: Istanbul Medeniyet University
Parkinson Disease · Multiple Sclerosis · Stroke · Upper Extremity Problem
Resting Postural Tremor in Multiple SclerosisUnknown
NCT04405479N/AUpdated Feb 6, 2024
Sponsor: Charles University, Czech Republic
Multiple Sclerosis
Czechia
Safety and Tolerability of ISX (Isoxsuprine HCL) in MS RelapsesCompleted
NCT03752307Phase 1, Phase 2Updated Feb 6, 2024
Sponsor: University of New Mexico
Multiple Sclerosis
United States
Study of Tysabri in Early Relapsing Remitting Multiple Sclerosis ParticipantsCompleted
NCT04832399N/AUpdated Feb 5, 2024
Sponsor: Biogen
Relapsing Remitting Multiple Sclerosis
Portugal
Epidemiological Characteristics of COVID-19 in Patients With MS or NMOCompleted
NCT04355611N/AUpdated Feb 5, 2024
Sponsor: Assistance Publique - Hôpitaux de Paris
Multiple Sclerosis · NMO Spectrum Disorder · COVID-19
France
Validation of the French Adaptation of the MSWDQ-23 QuestionnaireCompleted
NCT04860791N/AUpdated Feb 5, 2024
Sponsor: Centre Hospitalier Universitaire de Nice
Multiple Sclerosis
France
Study of Brain Activations and Physiological Responses Using NeuroBiofeedback in Patients With Multiple SclerosisUnknown
NCT06239090NAUpdated Feb 2, 2024
Sponsor: IRCCS Centro Neurolesi Bonino Pulejo
Multiple Sclerosis · Mood Disorders · Cognitive Impairment
Italy

Previous page Next page